Small cell lung cancer

Clinical Practice Guidelines in Oncology™

Bruce E. Johnson, Jeffrey Crawford, Robert J. Downey, David S. Ettinger, Frank Fossella, John C. Grecula, Thierry Jahan, Gregory P. Kalemkerian, Margaret Anne Kessinger, Marianna Koczywas, Corey J. Langer, Renato Martins, Maryanne Hoffman Marymont, Harvey B. Niell, Nithya Ramnath, Francisco Robert, Charles C. Williams

Research output: Contribution to journalReview article

37 Citations (Scopus)

Abstract

In 2005, approximately 26,000 new cases of small cell lung cancer were diagnosed in the United States. When compared with non-small cell lung cancer, SCLC generally has a more rapid doubling time, a higher growth fraction, and earlier development of widespread metastases. SCLC is highly sensitive to initial chemotherapy and radiotherapy. Treatment with chemotherapy plus chest radiotherapy can be curative for some patients with limited-stage SCLC, whereas most patients with extensive-stage disease who undergo chemotherapy alone experience palliated symptoms and prolonged survival. The updated 2006 NCCN guidelines include new principles of surgical resection as well as chemotherapy and radiation dosage changes.

Original languageEnglish (US)
Pages (from-to)602-622
Number of pages21
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume4
Issue number6
StatePublished - Jul 1 2006

Fingerprint

Small Cell Lung Carcinoma
Practice Guidelines
Drug Therapy
Radiotherapy
Radiation Dosage
Non-Small Cell Lung Carcinoma
Thorax
Guidelines
Neoplasm Metastasis
Survival
Growth
Therapeutics

Keywords

  • Carcinoma
  • Chemotherapy
  • Mediastinum
  • Metastases
  • NCCN Clinical Practice Guidelines
  • Pulmonary carcinogenesis
  • Radiotherapy
  • Small cell
  • Surgical resection
  • Targeted therapy

ASJC Scopus subject areas

  • Oncology

Cite this

Johnson, B. E., Crawford, J., Downey, R. J., Ettinger, D. S., Fossella, F., Grecula, J. C., ... Williams, C. C. (2006). Small cell lung cancer: Clinical Practice Guidelines in Oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 4(6), 602-622.

Small cell lung cancer : Clinical Practice Guidelines in Oncology™. / Johnson, Bruce E.; Crawford, Jeffrey; Downey, Robert J.; Ettinger, David S.; Fossella, Frank; Grecula, John C.; Jahan, Thierry; Kalemkerian, Gregory P.; Kessinger, Margaret Anne; Koczywas, Marianna; Langer, Corey J.; Martins, Renato; Marymont, Maryanne Hoffman; Niell, Harvey B.; Ramnath, Nithya; Robert, Francisco; Williams, Charles C.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 4, No. 6, 01.07.2006, p. 602-622.

Research output: Contribution to journalReview article

Johnson, BE, Crawford, J, Downey, RJ, Ettinger, DS, Fossella, F, Grecula, JC, Jahan, T, Kalemkerian, GP, Kessinger, MA, Koczywas, M, Langer, CJ, Martins, R, Marymont, MH, Niell, HB, Ramnath, N, Robert, F & Williams, CC 2006, 'Small cell lung cancer: Clinical Practice Guidelines in Oncology™', JNCCN Journal of the National Comprehensive Cancer Network, vol. 4, no. 6, pp. 602-622.
Johnson BE, Crawford J, Downey RJ, Ettinger DS, Fossella F, Grecula JC et al. Small cell lung cancer: Clinical Practice Guidelines in Oncology™. JNCCN Journal of the National Comprehensive Cancer Network. 2006 Jul 1;4(6):602-622.
Johnson, Bruce E. ; Crawford, Jeffrey ; Downey, Robert J. ; Ettinger, David S. ; Fossella, Frank ; Grecula, John C. ; Jahan, Thierry ; Kalemkerian, Gregory P. ; Kessinger, Margaret Anne ; Koczywas, Marianna ; Langer, Corey J. ; Martins, Renato ; Marymont, Maryanne Hoffman ; Niell, Harvey B. ; Ramnath, Nithya ; Robert, Francisco ; Williams, Charles C. / Small cell lung cancer : Clinical Practice Guidelines in Oncology™. In: JNCCN Journal of the National Comprehensive Cancer Network. 2006 ; Vol. 4, No. 6. pp. 602-622.
@article{510da461043a4f90a181949422456c6f,
title = "Small cell lung cancer: Clinical Practice Guidelines in Oncology™",
abstract = "In 2005, approximately 26,000 new cases of small cell lung cancer were diagnosed in the United States. When compared with non-small cell lung cancer, SCLC generally has a more rapid doubling time, a higher growth fraction, and earlier development of widespread metastases. SCLC is highly sensitive to initial chemotherapy and radiotherapy. Treatment with chemotherapy plus chest radiotherapy can be curative for some patients with limited-stage SCLC, whereas most patients with extensive-stage disease who undergo chemotherapy alone experience palliated symptoms and prolonged survival. The updated 2006 NCCN guidelines include new principles of surgical resection as well as chemotherapy and radiation dosage changes.",
keywords = "Carcinoma, Chemotherapy, Mediastinum, Metastases, NCCN Clinical Practice Guidelines, Pulmonary carcinogenesis, Radiotherapy, Small cell, Surgical resection, Targeted therapy",
author = "Johnson, {Bruce E.} and Jeffrey Crawford and Downey, {Robert J.} and Ettinger, {David S.} and Frank Fossella and Grecula, {John C.} and Thierry Jahan and Kalemkerian, {Gregory P.} and Kessinger, {Margaret Anne} and Marianna Koczywas and Langer, {Corey J.} and Renato Martins and Marymont, {Maryanne Hoffman} and Niell, {Harvey B.} and Nithya Ramnath and Francisco Robert and Williams, {Charles C.}",
year = "2006",
month = "7",
day = "1",
language = "English (US)",
volume = "4",
pages = "602--622",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "6",

}

TY - JOUR

T1 - Small cell lung cancer

T2 - Clinical Practice Guidelines in Oncology™

AU - Johnson, Bruce E.

AU - Crawford, Jeffrey

AU - Downey, Robert J.

AU - Ettinger, David S.

AU - Fossella, Frank

AU - Grecula, John C.

AU - Jahan, Thierry

AU - Kalemkerian, Gregory P.

AU - Kessinger, Margaret Anne

AU - Koczywas, Marianna

AU - Langer, Corey J.

AU - Martins, Renato

AU - Marymont, Maryanne Hoffman

AU - Niell, Harvey B.

AU - Ramnath, Nithya

AU - Robert, Francisco

AU - Williams, Charles C.

PY - 2006/7/1

Y1 - 2006/7/1

N2 - In 2005, approximately 26,000 new cases of small cell lung cancer were diagnosed in the United States. When compared with non-small cell lung cancer, SCLC generally has a more rapid doubling time, a higher growth fraction, and earlier development of widespread metastases. SCLC is highly sensitive to initial chemotherapy and radiotherapy. Treatment with chemotherapy plus chest radiotherapy can be curative for some patients with limited-stage SCLC, whereas most patients with extensive-stage disease who undergo chemotherapy alone experience palliated symptoms and prolonged survival. The updated 2006 NCCN guidelines include new principles of surgical resection as well as chemotherapy and radiation dosage changes.

AB - In 2005, approximately 26,000 new cases of small cell lung cancer were diagnosed in the United States. When compared with non-small cell lung cancer, SCLC generally has a more rapid doubling time, a higher growth fraction, and earlier development of widespread metastases. SCLC is highly sensitive to initial chemotherapy and radiotherapy. Treatment with chemotherapy plus chest radiotherapy can be curative for some patients with limited-stage SCLC, whereas most patients with extensive-stage disease who undergo chemotherapy alone experience palliated symptoms and prolonged survival. The updated 2006 NCCN guidelines include new principles of surgical resection as well as chemotherapy and radiation dosage changes.

KW - Carcinoma

KW - Chemotherapy

KW - Mediastinum

KW - Metastases

KW - NCCN Clinical Practice Guidelines

KW - Pulmonary carcinogenesis

KW - Radiotherapy

KW - Small cell

KW - Surgical resection

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=33747592358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747592358&partnerID=8YFLogxK

M3 - Review article

VL - 4

SP - 602

EP - 622

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 6

ER -